Cargando…

Advances in the treatment of metabolic diseases

Detalles Bibliográficos
Autor principal:	DiMarchi, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085582/ https://www.ncbi.nlm.nih.gov/pubmed/33729916 http://dx.doi.org/10.1016/j.molmet.2021.101208

Ejemplares similares

“Let's Stay Together”; GIP and GLP-1 dual agonism in the treatment of metabolic disease
por: DiMarchi, Richard D.
Publicado: (2018)

A glucagon analog chemically stabilized for immediate treatment of life-threatening hypoglycemia()
por: Chabenne, Joseph, et al.
Publicado: (2014)

Anti-obesity drug discovery: advances and challenges
por: Müller, Timo D., et al.
Publicado: (2021)

Recent Advances in Incretin-Based Pharmacotherapies for the Treatment of Obesity and Diabetes
por: Tan, Qiming, et al.
Publicado: (2022)

Outstanding Scientific Achievement Award Lecture 2011: Defeating Diabesity: The Case for Personalized Combinatorial Therapies
por: Tschöp, Matthias H., et al.
Publicado: (2012)

Smarter Modeling to Enable a Smarter Insulin
por: Taylor, Simeon I., et al.
Publicado: (2020)

Peptide Conjugates with Small Molecules Designed to Enhance Efficacy and Safety
por: He, Rongjun, et al.
Publicado: (2019)

GIP receptor agonism improves dyslipidemia and atherosclerosis independently of body weight loss in preclinical mouse model for cardio-metabolic disease
por: Sachs, Stephan, et al.
Publicado: (2023)

GLP-1/glucagon receptor co-agonism for treatment of obesity
por: Sánchez-Garrido, Miguel A., et al.
Publicado: (2017)

A viral insulin-like peptide is a natural competitive antagonist of the human IGF-1 receptor
por: Zhang, Fa, et al.
Publicado: (2021)

Targeting the Incretin/Glucagon System With Triagonists to Treat Diabetes
por: Capozzi, Megan E, et al.
Publicado: (2018)

Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis
por: Tiano, Joseph P., et al.
Publicado: (2015)

A Facile Procedure for One-Pot Stable Conjugation of Two Proglucagon Cysteine-Containing Peptide Analogs
por: He, Rongjun, et al.
Publicado: (2021)

OR28-5 Bile Acid Sequestration Accelerates Glucagon Receptor-Mediated Body Weight Loss in Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2019)

Advances in Diagnosis and Treatment of Biliopancreatic Diseases
por: Maluf-Filho, Fauze, et al.
Publicado: (2012)

Latest advances in the treatment of corneal diseases
por: Wang, I-Jong
Publicado: (2015)

Advances in the science and treatment of respiratory diseases
por: Chung, Jin Hong
Publicado: (2020)

Gαs regulates Glucagon-Like Peptide 1 Receptor-mediated cyclic AMP generation at Rab5 endosomal compartment
por: Girada, Shravan Babu, et al.
Publicado: (2017)

SAT-655 Bile Acid Sequestration Synergistically Accelerates Glucagon Receptor-Stimulated Body Weight Loss in Diet-Induced Obese Mice
por: Kim, Teayoun, et al.
Publicado: (2020)

Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances
por: Kassi, Eva, et al.
Publicado: (2023)

Molecular Advances in Microbial Metabolism
por: Martínez-Espinosa, Rosa María, et al.
Publicado: (2023)

Advances in Parkinson’s Disease Drugs
por: Di Stefano, Antonio, et al.
Publicado: (2021)

Hypothalamic Glucagon Receptors Regulate Feeding in Mice
por: Cunningham, Stephen E, et al.
Publicado: (2021)

Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism
por: Mroz, Piotr A., et al.
Publicado: (2018)

Fibroblast activation protein (FAP) as a novel metabolic target
por: Sánchez-Garrido, Miguel Angel, et al.
Publicado: (2016)

Advanced knowledge in drug metabolism and pharmacokinetics
por: Yu, Ai-Ming, et al.
Publicado: (2016)

Advances in Cancer Metabolism and Tumour Microenvironment
por: Smetana, Karel, et al.
Publicado: (2022)

Advances in Metabolic Profiling of Biological Samples
por: Pinto, Joana
Publicado: (2023)

Targeting lipogenesis in the treatment of metabolic diseases and cancer
por: Viscarra, Jose A., et al.
Publicado: (2017)

Advance in Genomics of Rare Genetic Diseases
por: Sommariva, Elena, et al.
Publicado: (2023)

Advances of interventional radiology in treatment of hepatobiliary diseases in Iran
por: Ghanaati, Hossein, et al.
Publicado: (2011)

Clinical Advances in the Diagnosis and Treatment of Biliary Tract Diseases
por: Matsubara, Saburo
Publicado: (2023)

Advances in Computational Methods for Genetic Diseases
por: Camastra, Francesco, et al.
Publicado: (2015)

Emerging Advancements in Canine and Feline Metabolism and Nutrition
por: Shoveller, Anna K., et al.
Publicado: (2016)

Special Issue on “Advances in Cholesterol and Lipid Metabolism”
por: Reiss, Allison B., et al.
Publicado: (2022)

Advances in Nitric Oxide Signalling and Metabolism in Plants
por: Liao, Weibiao, et al.
Publicado: (2023)

Advances in Neurodegenerative Diseases
por: Van Schependom, Jeroen, et al.
Publicado: (2023)

From Biomarkers to Precision Medicine in Neurodegenerative Diseases: Where Are We?
por: Tondo, Giacomo, et al.
Publicado: (2022)

Special Issue “Clinical Advances in Chronic Intestinal Diseases Treatment”
por: Latorre, Eva, et al.
Publicado: (2022)

Advances in Graves' Disease
por: Galofré, Juan C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_d3l8t6s3bniirtgp0veu6gd7jg